Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells

Author： Dige Anders   Hvas Christian Lodberg   Deleuran Bent   Kelsen Jens   Bendix-Struve Mia   Dahlerup Jens Frederik   Agnholt Jørgen  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.46, Iss.10, 2011-10, pp. : 1206-1214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Crohn's disease diagnosis during adalimumab treatment

By Fernández Salazar Luis   Barrio Andrés Jesús   González Hernández José Manuel  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 2, 2013-02 ,pp. : 254-255

Informa Healthcare

Access to resources Recommend Favorite

Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients

By Reikvam Dag Henrik   Perminow Gøøri   Lyckander Lars Gustav   Gran Jon Michael   Brandtzaeg Per   Vatn Morten   Carlsen Hege S.  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 5, 2011-05 ,pp. : 550-560

Informa Healthcare

Access to resources Recommend Favorite

Early Intervention with Adalimumab May Contribute to Favorable Clinical Efficacy in Patients with Crohn's Disease

By  

Digestion, Vol. 90, Iss. 2, 2014-10 ,pp. : 130-136

Karger

Access to resources Recommend Favorite

Adalimumab-induced psoriasis in a patient with Crohn's disease

By Korkmaz Ugur  

Indian Journal of Gastroenterology, Vol. 32, Iss. 2, 2013-03 ,pp. : 135-136

Springer Publishing Company

Access to resources Recommend Favorite

Deficiency of Invariant NK T Cells in Crohn's Disease and Ulcerative Colitis

By Grose Randall   Thompson Fiona   Baxter Alan   Pellicci Daniel   Cummins Adrian  

Digestive Diseases and Sciences, Vol. 52, Iss. 6, 2007-06 ,pp. : 1415-1422

Springer Publishing Company

Access to resources Recommend Favorite